Tekla Historical Income Statement
| HQH Stock | USD 17.40 0.10 0.58% |
Historical analysis of Tekla Healthcare income statement accounts such as Selling General Administrative of 2.5 M or Total Revenue of 70.2 M can show how well Tekla Healthcare Investors performed in making a profits. Evaluating Tekla Healthcare income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Tekla Healthcare's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Tekla Healthcare Inv latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Tekla Healthcare Inv is a good buy for the upcoming year.
Tekla |
About Tekla Income Statement Analysis
Tekla Healthcare Inv Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Tekla Healthcare shareholders. The income statement also shows Tekla investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Tekla Healthcare Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Tekla Healthcare Inv. It is also known as Tekla Healthcare overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Tekla Healthcare Inv income statement and represents the costs associated with goods and services Tekla Healthcare provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Tekla Healthcare's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Tekla Healthcare Inv current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. As of now, Tekla Healthcare's Operating Income is increasing as compared to previous years. The Tekla Healthcare's current Net Interest Income is estimated to increase to about 748.7 K, while Depreciation And Amortization is projected to decrease to under 1 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 2.0M | 1.8M | 2.1M | 1.9M | Cost Of Revenue | 11.3M | 10.9M | 12.5M | 7.3M |
Tekla Healthcare income statement Correlations
Click cells to compare fundamentals
Tekla Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tekla Healthcare income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 2.0M | 6.2M | 3.7M | 1.2M | 1.1M | 1.0M | |
| Selling General Administrative | 1.2M | 1.3M | 1.4M | 1.2M | 1.4M | 2.5M | |
| Total Revenue | 242.9M | 157.1M | (192.3M) | 58.1M | 66.8M | 70.2M | |
| Gross Profit | 242.9M | 157.1M | (192.3M) | 58.1M | 66.8M | 70.2M | |
| Other Operating Expenses | 1.7M | 1.9M | 2.0M | 1.8M | 2.1M | 1.9M | |
| Operating Income | 241.2M | 155.2M | (194.2M) | 56.3M | 64.8M | 68.0M | |
| Ebit | 241.2M | 155.2M | (194.2M) | 56.3M | 64.8M | 35.7M | |
| Ebitda | 243.2M | 161.4M | (190.6M) | 56.3M | 64.8M | 64.1M | |
| Cost Of Revenue | 10.0M | 11.8M | 11.3M | 10.9M | 12.5M | 7.3M | |
| Total Operating Expenses | 1.7M | 1.9M | 2.0M | 1.8M | 2.1M | 1.9M | |
| Income Before Tax | 241.2M | 155.2M | (194.2M) | 56.3M | 64.8M | 48.6M | |
| Total Other Income Expense Net | (25.3K) | (17.8K) | 5.5K | (4.0K) | (3.6K) | (3.4K) | |
| Net Income | 241.2M | 155.2M | (194.2M) | 56.3M | 64.8M | 48.6M | |
| Net Income From Continuing Ops | 241.2M | 155.2M | (194.2M) | 56.3M | 50.7M | 37.1M | |
| Net Income Applicable To Common Shares | (145.3M) | 241.2M | 155.2M | (194.2M) | (174.8M) | (166.1M) | |
| Income Tax Expense | (2.0M) | (6.2M) | (3.7M) | (1.2M) | (1.1M) | (1.1M) | |
| Interest Income | 265.1K | 161.3M | 112.3K | 620.0K | 558.0K | 530.1K | |
| Net Interest Income | 287.6K | 265.1K | 112.3K | 620.0K | 713.0K | 748.7K | |
| Research Development | 2.62 | 1.74 | 2.6 | 0.56 | 0.5 | 0.48 |
Currently Active Assets on Macroaxis
When determining whether Tekla Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tekla Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tekla Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tekla Healthcare Investors Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Healthcare. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.145 | Dividend Share 1.66 | Earnings Share 1.31 | Revenue Per Share 0.197 | Quarterly Revenue Growth (0.06) |
The market value of Tekla Healthcare Inv is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tekla Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Healthcare's market value can be influenced by many factors that don't directly affect Tekla Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.